Beijing Wanquan Sunshine Pharmaceutical Technology

Beijing Wanquan Sunshine Pharmaceutical Technology is a prominent Chinese contract research organization (CRO) and drug development company, operating as a key subsidiary of the Venturepharm Group. The company offers a full suite of services ranging from preclinical research and clinical trial management to regulatory submission and generic drug consistency evaluation. Beyond its service offerings, it develops a proprietary pipeline of small molecule therapeutics focusing on the central nervous system, cardiovascular health, and metabolic diseases. Beijing Wanquan Sunshine is recognized for its extensive experience in the Chinese regulatory environment and its role in bringing both generic and innovative medicines to the local market.